The retension rate and tolerability of fingolimod in relapsed remitting multiple sclerosis patients who switched from other oral DMTs
Latest Information Update: 08 May 2017
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 08 May 2017 New trial record
- 28 Apr 2017 Results (n=386) presented at the 69th Annual Meeting of the American Academy of Neurology